Poster
Engineering an isogenic APP Swedish human iPSC-derived cortical neuron model of Familial Alzheimer’s disease that recapitulates hallmark amyloid and tau pathologies
Describing an isogenic human iPSC-derived cortical neuron model of familial Alzheimer’s disease, created by introducing the APP Swedish (K670N/M671L) mutation into healthy-donor PBMC-derived iPSCs, with matched parental WT controls and validated amyloid and phospho-tau phenotypes.

Overview
Comparisons between unrelated iPSC donor lines are confounded by genetic background, limiting their value for modeling Alzheimer’s disease. We reprogrammed healthy-donor PBMCs into iPSCs via integration-free Sendai virus, confirmed donor STR identity, vector clearance, normal karyotype, pluripotency markers, and trilineage potential, then introduced the APP Swedish mutation by genome editing. Three validated APPswe clones retained NANOG/OCT4 expression. WT and APPswe clones differentiated into cortical neurons expressing NeuN and MAP2, with voltage-gated Na⁺/K⁺ currents, evoked and spontaneous action potentials, and high TfR and CD98 expression. APPswe neurons showed significantly elevated Aβ42, Aβ40, total Aβ, phospho-tau217, and phospho-tau181 versus isogenic controls.
Key Insights
An isogenic APP Swedish iPSC-derived cortical neuron model, built on a fully characterized healthy-donor background, reproduces hallmark amyloid and phospho-tau phenotypes of familial Alzheimer’s disease against matched wild-type controls.
- Genetic background controlled by design. The APPswe mutation was edited directly into a validated healthy-donor iPSC line, so parental WT cells serve as matched isogenic controls and phenotype differences cannot be attributed to donor-to-donor variability.
- Functional neurons, not just marker-positive cells. Differentiated cultures from both genotypes expressed NeuN and MAP2 and showed voltage-gated Na⁺/K⁺ currents, evoked action potentials, and spontaneous firing by patch clamp, alongside high TfR and CD98 expression relevant to BBB shuttle studies.
- Clear, multi-biomarker AD phenotype. APPswe neurons showed roughly 3-fold higher Aβ42, 5-fold higher Aβ40 and total Aβ, 2.5-fold higher phospho-tau217, and 8-fold higher phospho-tau181 than isogenic WT controls (n = 3 per group).
Unlock Advanced Research Insights with Cyagen’s Resources
Explore an array of valuable resources tailored to enhance your preclinical research. Download mateirals meticulously crafted to provide advanced insights and methodologies. Elevate your research strategies with Cyagen's expertise.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
